Company: DARE
Filing Date: 2025-04-24
Form Type: ARS
Source: 0001401914-25-000018
Chunk: 322

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: ARS
Chunk 322
---
,264 Other advanced clinical stage programs 1,321,888 3,498,955 Phase 1 and Phase 1-ready clinical stage programs 761,721 2,912,857 Preclinical stage programs 4,233,762 7,432,439 Other development programs 27,542 189,706 Contra-R&D expenses (7,685,533) (8,965,347) Total research and development direct program costs 9,538,927 16,577,485 Indirect costs: Personnel-related (including stock compensation) 5,611,057 5,566,016 Other indirect costs 254,772 384,289 Contra R&D expenses (1,199,548) (989,716) Total research and development indirect costs 4,666,281 4,960,589 General and administrative 9,156,061 12,109,691 Other operating expenses 100,000 100,000 Total segment operating expenses 23,461,269 33,747,765 Loss from operations (23,451,485) (30,939,880) Sale of royalty and milestone rights, net 20,379,376 — Interest expense 857,364 35,109 Interest income (539,743) (813,278) Other income (expense), net 663,869 (320) Net loss $ (4,053,599) $ (30,161,391) F-36

17. SUBSEQUENT EVENTS Noncompliance with Nasdaq’s Minimum Market Value of Listed Securities Requirement On August 12, 2024, the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying it that it did not meet the requirement in Nasdaq Listing Rule 5550(b)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(2) requires a company listed on Nasdaq to maintain a minimum market value of listed securities of $35.0 million (the “Minimum MVLS Rule”). The Company was provided an initial period of 180 calendar days, or until February 10, 2025, to regain compliance with the Minimum MVLS Rule. On February 13, 2025, Nasdaq’s Listing Qualifications Department notified the Company that because it did not regain compliance with the Minimum MVLS Rule by February 10, 2025, its common stock is subject to delisting from Nasdaq unless the Company timely